title: Difficult management of triple therapy for chronic hepatitis C in a patient on haemodialysis.
authors.affiliation: Servicio de Digestivo, Consorcio Hospital General Universitario Valencia, Valencia, España.
authors.forename: Lydia
authors.initials: L
authors.lastname: Plana
authors.affiliation: Servicio de Digestivo, Consorcio Hospital General Universitario Valencia, Valencia, España. Electronic address: laublava@gmail.com.
authors.forename: Laura
authors.initials: L
authors.lastname: Peño
authors.affiliation: Servicio de Digestivo, Consorcio Hospital General Universitario Valencia, Valencia, España.
authors.forename: Juan José
authors.initials: JJ
authors.lastname: Urquijo
authors.affiliation: Servicio de Digestivo, Consorcio Hospital General Universitario Valencia, Valencia, España.
authors.forename: Moisés
authors.initials: M
authors.lastname: Diago
mesh_terms: D000743:Anemia, Hemolytic / Q000139:chemically induced / Q000628:therapy; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016470:Bacteremia / Q000150:complications; D016913:Blood Component Transfusion; D055499:Catheter-Related Infections / Q000150:complications; D004359:Drug Therapy, Combination; D005921:Glomerulonephritis / Q000150:complications; D006084:Graft Rejection; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000601:surgery / Q000628:therapy; D016030:Kidney Transplantation; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000008:administration & dosage / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000209:etiology; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D006435:Renal Dialysis; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000150:complications; D013921:Thrombocytopenia / Q000209:etiology / Q000628:therapy
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D009842:Oligopeptides; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C486464:telaprevir; C100416:peginterferon alfa-2a